Yuichi Honma

10PUBLICATIONS
29CO-AUTHORS
Nutrigenomics and personalised nutritionPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Dynamic Nutritional Decline During the Diagnostic-to-Treatment Interval Is Associated with Treatment Resilience and Survival in Unresectable Pancreatic Ductal Adenocarcinoma.

|Aug 21, 2025
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study.

Takeshi Hatanaka, Shigeo Shimose, Takanori Ito

|May 28, 2025
A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.

Tetsu Tomonari, Shigeo Shimose, Issei Saeki

|Apr 26, 2025
Usefulness of the Early Increase of Peripheral Blood Lymphocyte Count in Predicting Clinical Outcomes for Patients with Advanced Hepatocellular Carcinoma Treated with Durvalumab Plus Tremelimumab.

Yuichi Honma, Michihiko Shibata, Masatoshi Ikemi

|Nov 17, 2023
Metabolic management after sustained virologic response in elderly patients with hepatitis C virus: A multicenter study.

Tomoya Sano, Keisuke Amano, Tatsuya Ide

|Sep 13, 2022
Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C.

Yuichi Honma, Michihiko Shibata, Kahori Morino

Pageof 2

Frequent Collaborators

3 joint publications

Takumi Kawaguchi

3 joint publications

Masaru Harada

2 joint publications

Sohji Nishina

2 joint publications

Hisamitsu Miyaaki